BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36375657)

  • 21. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
    Dong Z; Chang X; Xie L; Wang Y; Hou Y
    Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsatilla saponin E suppresses viability, migration, invasion and promotes apoptosis of NSCLC cells through negatively regulating Akt/FASN pathway
    Zhu M; Shi W; Chen K; Hu H; Ye X; Jiang Y
    J Recept Signal Transduct Res; 2022 Feb; 42(1):23-33. PubMed ID: 33243063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    Huang LH; Chung HY; Su HM
    BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of CCT3 promotes cervical cancer progression through FN1.
    Dou L; Zhang X
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
    Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
    Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
    Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
    Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
    Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
    Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
    J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
    [No Abstract]   [Full Text] [Related]  

  • 33. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
    Huang Y; Wu Q; Tan X
    Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
    Zhang W; Huang J; Tang Y; Yang Y; Hu H
    Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
    Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
    Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
    J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of FASN inhibition in preclinical models of HCC.
    Wang H; Zhou Y; Xu H; Wang X; Zhang Y; Shang R; O'Farrell M; Roessler S; Sticht C; Stahl A; Evert M; Calvisi DF; Zeng Y; Chen X
    Hepatology; 2022 Oct; 76(4):951-966. PubMed ID: 35076948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FASN promotes gallbladder cancer progression and reduces cancer cell sensitivity to gemcitabine through PI3K/AKT signaling.
    Cheng H; Sun Y; Yu X; Zhou D; Ding J; Wang S; Ma F
    Drug Discov Ther; 2023 Nov; 17(5):328-339. PubMed ID: 37743521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.